Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
Integer Holdings' (ITGR) Latest Buyout to Expand Its Footprint
04:38pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Integer Holdings' (ITGR) buyout of Aran Biomedical is set to expand its presence in high-growth markets as well as enhance its product offerings.
Masimo's (MASI) Sound United Buyout to Boost Product Portfolio
02:34pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Masimo's (MASI) completion of Sound United's buyout to help enhance the former's extended portfolio of hospital and home medical technology solutions.
Illumina (ILMN) Launches Genomic Solution Hub in Brazil
02:10pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Illumina's (ILMN) customers and partners in Brazil currently span basic research, applied markets to clinical labs and healthcare institutions.
NEOGEN (NEOG) Adds to Prozap Insect Control Product Line-up
02:09pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
NEOGEN's (NEOG) latest Prozap Protectus Pour-On Insecticide- IGR product relieves cattle from infestations.
Here's Why You Should Hold on to Cardiovascular Systems (CSII)
02:07pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Investors are optimistic about Cardiovascular Systems' (CSII) robust international growth and upcoming launches.
Here's Why You Should Retain SmileDirectClub (SDC) For Now
01:04pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Investors are optimistic about SmileDirectClub's (SDC) series of cutting-edge innovation, strategic distribution and insurance partnerships.
Bruker (BRKR) Unveils New Imaging Tools for Cancer Research
12:54pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Bruker's (BRKR) latest innovation for cancer research is likely to strengthen the company's opportunities in proteomics and spatial biology.
IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists
02:46pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
Here's Why You Should Retain Boston Scientific (BSX) For Now
02:42pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Investors are optimistic about Boston Scientific's (BSX) robust organic sales and strategic buyouts.
Merit Medical's (MMSI) SCOUT Bx Delivery System Gets FDA Nod
02:39pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Merit Medical's (MMSI) receipt of FDA clearance for the SCOUT Bx system can streamline treatment for cancer patients.
Alcon (ALC) Stock Rallies 4.7% Since Posting Q4 Earnings Beat
02:36pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.
Quidel Corporation (QDEL) Reports Solid Preliminary Q1 Revenues
02:10pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Quidel's (QDEL) revenue growth in the first quarter is likely to have been boosted by continued robust sales of its SARS-related products.
Here's Why You Should Retain Thermo Fisher (TMO) For Now
02:01pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.
Here's Why You Should Hold on to Walgreens Boots (WBA) For Now
04:58pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about Walgreens (WBA) owing to the recent product launches.
The Zacks Analyst Blog Highlights Becton Dickinson, Phibro Animal Health, McKesson, and UnitedHealth Group
04:17pm, Monday, 11'th Apr 2022 Zacks Investment Research
Becton Dickinson, Phibro Animal Health, McKesson, and UnitedHealth Group are part of top Analyst Blog.
